Article Information
- Received June 12, 2017
- Revision received April 7, 2018
- Accepted May 3, 2018
- First published May 16, 2018.
- Version of record published June 6, 2018.
Author Information
- Saray López-Benito1,2,
- Julia Sánchez-Sánchez1,2,
- Verónica Brito3,4,5,
- Laura Calvo1,2,
- Silvia Lisa1,2,
- María Torres-Valle1,2,
- Mary E. Palko6,
- Cristina Vicente-García1,2,
- Seila Fernández-Fernández7,8,
- Juan P. Bolaños2,7,8,
- Silvia Ginés3,4,5,
- Lino Tessarollo6, and
- Juan C. Arévalo1,2
- 1Department of Cell Biology and Pathology, Instituto de Neurociencias de Castilla y León, University of Salamanca, Salamanca 37007, Spain,
- 2Institute of Biomedical Research of Salamanca, Salamanca 37007, Spain,
- 3Departament de Biomedicina, Universitat de Barcelona, Barcelona 08036, Spain,
- 4Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona 08036, Spain,
- 5Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Barcelona 08036, Spain,
- 6Neural Development Group, Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702,
- 7Department of Biochemistry and Molecular Biology, University of Salamanca, Salamanca 37007, Spain, and
- 8Institute of Functional Biology and Genomics, University of Salamanca-CSIC, 37007 Salamanca, Spain
Author contributions
Author contributions: S.L.-B. and J.C.A. designed research; S.L.-B., J.S.-S., V.B., L.C., S.L., M.T.-V., M.E.P., C.V.-G., S.G., and J.C.A. performed research; S.F.-F., J.P.B., and L.T. contributed unpublished reagents/analytic tools; S.L.-B., J.S.-S., V.B., S.L., S.G., L.T., and J.C.A. analyzed data; S.L.-B. and J.C.A. wrote the paper.
Disclosures
- Received June 12, 2017.
- Revision received April 7, 2018.
- Accepted May 3, 2018.
The authors declare no competing financial interests.
This work was supported by MINECO BFU2011-22898, BFU2014-51846-R, and BFU2017-82667-R to J.C.A. and SAF2013-41177-R to J.P.B., and the EU 7th Framework Program (Marie Curie IRG and PAINCAGE) to J.C.A. S.L.-B. was supported by Consejería de Educación Junta de Castilla y León and the European Social Fund. M.E.P. and L.T. were supported by the National Institutes of Health Intramural Research Program, Center for Cancer Research, National Cancer Institute. We thank Dionisio Martín-Zanca, Pilar Pérez, Moses V. Chao, Rubén Deogracias, and members of the J.C.A. laboratory for helpful discussions; Teresa Iglesias and Giampietro Schiavo for ARMS/Kidins220 antibody (GSC16); Michel Sadelain, Philippe Soriano, Didier Trono, and Jane Sullivan for plasmids; and BT-CIEN and Biobanco Hospital Universitario Fundación Alcorcón for human samples.
The authors declare no competing financial interests.
- Correspondence should be addressed to Dr. Juan C. Arévalo, Department of Cell Biology and Pathology, Instituto de Neurociencias de Castilla y León, Universidad de Salamanca, C/Pintor Fernando Gallego 1, Laboratorio 3, 37007 Salamanca, Spain. arevalojc{at}usal.es
Other Version
- previous version (May 16, 2018).
- You are viewing the most recent version of this article.
Online Impact